Bilgin Bahadır BAŞGÖZ, Buse HACIOĞLU, Cevdet Furkan KÖŞKER, Musa Barış AYKAN, Semra İNCE, İlker TAŞÇI, Ahmet Burak BİLEKLİ, Alev ÇINAR

Does ABO blood type is a novel risk factor for osteoporosis or low bone density among postmenopausal women or not?

ABO blood types may cause a vulnerability to individuals for conditions such as malignancies or chronic diseases. However, the interaction of ABO blood types and osteoporosis is inexplicit. In this study, we focused on the role of ABO blood types on bone health by comparing bone mineral density (BMD), and the prevalence of low bone mass (LBM) and osteoporosis among postmenopausal women. Non-institutionalized postmenopausal women aged over 50 years were prospectively enrolled in the study following the measurement of BMD by dual-energy X-ray absorptiometry (DEXA). The prevalence of osteoporosis and LBM were interpreted according to T scores of either site. Self-reported blood types of participants were noted. The study included 220 postmenopausal women, and the median age of participants were 59 (11) years (min:50 years, and max:82 years). The mean BMD values at the lumbar spine, femoral total, and femoral neck of participants were 0.821±0.118 g/cm2, 0.810±0.121 g/cm2, and 0.716±0.112 g/cm2, respectively. Both mean BMD and T scores of enrollees for either site were similar across blood types (p-value >0.05 for all). The prevalence of osteoporosis and LBM showed no significant association between blood groups (p=0.45, and p=0.226, respectively).The present study showed evidence of a similar BMD, the prevalence of LBM, and osteoporosis among postmenopausal women over 50 years regardless of ABO blood type.

PDF

___

1. Cauley JA, Thompson DE, Ensrud KC, et al. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556–61.
2. Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29:2520–6.
3. U.S. Preventive Services Task Force.Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med. 2011;154:356–65.
4. Brauer CA, Coca-Perraillon M, Cutler DM, et al. Incidence and mortality of hip fractures in the United States. JAMA - J Am Med Assoc. 2009;302:1573–9.
5. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.
6. Filip R, Radzki RP, Bieńko M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging. 2018;13:1879–91.
7. Lee SH, Khang Y-H, Lim K-H, et al. Clinical risk factors for osteoporotic fracture: a population-based prospective cohort study in Korea. J Bone Miner Res. 2010;25:369–78.
8. Seyfizadeh N, Seyfizadeh N, Negahdar H, et al. ABO Blood Group and Prevalence of Osteoporosis and Osteopenia in the Elderly Population: An Amirkola Health and Ageing Project (AHAP)-Based Study. J Clin Densitom. 2018;21:200–4.
9. Wolpin BM, Kraft P, Xu M, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2010;19:3140–9.
10. Lu B-B, Li K-H. Association between ABO blood groups and osteoporosis severity in Chinese adults aged 50 years and over. J Int Med Res. 2011;39:929–33.
11. Choi JW, Pai SH. Associations between ABO blood groups and osteoporosis in postmenopausal women. Ann Clin Lab Sci. 2004;34:150–3.
12. Kaur M. Association between ABO blood group and osteoporosis among postmenopausal women of North India. Homo. 2014;65:516–21.
13. Cosman F, De Beur SJ, Leboff MS, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int . 2014;25:2359-81.
14. Meo SA, Rouq FA, Suraya F, et al. Association of ABO and Rh blood groups with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2016;20:237–42.
15. Qureshi MA, Bhatti R. Frequency of ABO blood groups among the diabetes mellitus type 2 patients. J Coll Physicians Surg Pak. 2003;13:453–5.
16. Gotsman I, Keren A, Zwas DR, et al. Clinical Impact of ABO and Rhesus D Blood Type Groups in Patients With Chronic Heart Failure. Am J Cardiol. 2018;122:413–9.
17. Mandato VD, Torricelli F, Mastrofilippo V, et al. Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J Cancer. 2017;8:2828–35.
18. Yildiz B, Erturk I, Karadurmus N, et al. Prognostic value of ABO blood group in patients with nonseminomatous testicular cancer who treated with autologous stem cell transplantation. J Oncol Sci. 2018;4:70–3.
19. Ejezie FE OE. Fasting blood glucose levels in different haemoglobin genotypes and blood groups. Int J Med Heal Dev. 2003;8:53–5.
20. Lu BB, Li KH. Association between ABO blood groups and osteoporosis severity in Chinese adults aged 50 years and over. J Int Med Res. 2011;39:929–33.